Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EBIT Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) -8.272.0011.90-5.320.04

What is the latest EBIT Growth ratio of MEDICAMEN BIOTECH ?

The latest EBIT Growth ratio of MEDICAMEN BIOTECH is -8.27 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar2024-8.27
Mar20232.00
Mar202211.90
Mar2021-5.32
Mar20200.04

How is EBIT Growth of MEDICAMEN BIOTECH Trending?

Years EBIT Growth % Change
Mar2024 -8.27
Negative
Mar2023 2
-83.19
Mar2022 11.9
Positive
Mar2021 -5.32
Negative
Mar2020 0.04 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EBIT Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹468.0 Cr -2.3% -10.3% -17.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,466.0 Cr -3% -6.8% -11.3% Stock Analytics
DIVIS LABORATORIES ₹162,423.0 Cr -0.5% -8.4% 25.1% Stock Analytics
CIPLA ₹128,405.0 Cr -0.2% 1% -1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,448.0 Cr -3.4% -5.6% 6.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,411.0 Cr -1.1% -2.9% -9.5% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-2.3%

-10.3%

-17.5%

SENSEX

-2.7%

-1.3%

-2.3%


You may also like the below Video Courses